Close Menu

NEW YORK (360Dx) – Oxford Immunotec announced today that it expects to report fourth quarter revenue between $24.9 and $25.4 million, compared to prior guidance of $25.4 to $26.4 million.

The Q4 revenues would fall short of the consensus Wall Street estimate of $26.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.